12/12/2018Luye Pharma Files IND for CNS Drug LY03003 in Japan

12/11/2018USFDA Warns Zhejiang Huahai for Failure to Detect Valsartan API Impuri...

12/11/2018Aurobindo Subsidiary and Luoxin Agree to Form Chinese JV

12/11/2018Junshi Biosciences Aims to Raise $414M in Proposed Hong Kong IPO

12/11/2018Lonza to Establish Strategic Biomanufacturing Base in China

12/11/2018HitGen and Mitsubishi Tanabe Pharma Enter Discovery Research Partnersh...

12/11/2018UCB Announces Chinese Approval of Seizure Drug VIMPAT

12/10/2018NH Reports on Chinese OTC Sleep Aids Market in MAT Q3/2018

12/10/2018NH: Chinese OTC Market Growth Steady in MAT Q3 2018, Outpacing Global ...

12/10/2018CBT Pharma and Strata Oncology Tie Up to Accelerate Development of c-M...

12/10/2018WuXi AppTec Expands Site in California for Pharmaceutical R&D ...

12/9/2018Gilead Launches HBV Drug Vemlidy in China

12/7/2018National Centralized Drug Purchase Trial Upsets Pharma Industry with C...

12/7/2018Recent Executive Moves

12/7/2018SAMR Fines Three Violators as It Steps Up Anti-monopoly Crackdown on A...

12/7/2018State Council Approves Patent Amendment Draft and Policies to Boost In...

12/7/2018Brii Bio Announced Partnerships to Jump-start Pipeline with Focus on H...

12/7/2018Oral Insulin Moves Towards Becoming Reality in U.S., China

12/7/2018IFPMA and RDPAC Introduce New Code for Pharmaceutical Marketing Practi...

12/5/2018China Introduces A Range of New Punishments for IP Violations

12/5/2018Changzhou Qianhong Biopharma Expands Facility for Polysaccharides and ...

12/5/2018PAREXEL and Eli Lilly to Develop Chinese Clinical Research Workforce

12/5/2018Wuxi AppTec Says US Hurdles Will Not Dim Acquisition Appetite

12/5/2018BeiGene Mounts Its Assault On The Ibrutinib Hegemony

12/5/2018NMPA Approves Gilead's HIV Combo Drug Descovy

12/5/2018Insurer Manulife-Sinochem Inks Deal with Healthcare Platform 111 Inc.

12/5/2018Innovent Gains US FDA Approval to Initiate Clinical Trials for its Ant...

12/5/2018China Approves New Indication of J&J's Prostate Cancer Drug ZYTIGA

12/4/2018Revance Licenses China Rights of Neuromodulator RT002 to Fosun Pharma

12/4/2018Roche’s Hemlibra (emicizumab) Approved for Import and Marketing in Ch...

Page:252/726 Total number of articles:21776: [First][<<] [250] [251] [252] [253] [254] [>>] [End]